Skip to main content
Premium Trial:

Request an Annual Quote

European Commission Gives Deerac $743K to Develop New Liquid Handling Technology

NEW YORK, Aug. 29 (GenomeWeb News) - Deerac Fluidics has been awarded a 48-month contract worth €604,135 ($743,086) by the European Commission to develop new low-volume liquid-handling technology, the company said today.


According to the Dublin, Ireland-based company, the contract will fund a project entitled "Development of Instantaneous Low Volume Drop Measurement Device." The technology, Deerac said, will expand upon its Spot-on non-contact liquid handling technology, which is used for genomics, proteomics, and high-throughput screening applications.

The Scan

Could Cost Billions

NBC News reports that the new Alzheimer's disease drug from Biogen could cost Medicare in the US billions of dollars.

Not Quite Sent

The Biden Administration likely won't meet its goal of sending 80 million SARS-CoV-2 vaccine doses abroad by the end of the month, according to the Washington Post.

DTC Regulation Proposals

A new report calls on UK policymakers to review direct-to-consumer genetic testing regulations, the Independent reports.

PNAS Papers on Mosquito MicroRNAs, Acute Kidney Injury, Trichothiodystrophy

In PNAS this week: microRNAs involved in Aedes aegypti reproduction, proximal tubule cell response to kidney injury, and more.